HLA-J: A Potential Drug Target and Biomarker (G3137)

Target Name: HLA-J

NCBI ID: G3137

Other Name(s): MGC71446 | HLA-59 | HLA-CDA12 | Major histocompatibility complex, class I, J (pseudogene) | D6S203 | MGC105145 | CDA12 | major histocompatibility complex, class I, J (pseudogene)

HLA-J: A Potential Drug Target and Biomarker

HLA-J (MGC71446) is a human leukocyte antigen (HLA) class I molecule that is expressed in various tissues and cell types in the human body. HLA-J is a key molecule in the immune system, as it is the receptor for the T-cell receptor (TCR), which is responsible for triggering an immune response. Despite its importance in the immune system, HLA-J has also been identified as a potential drug target and biomarker.

Drug Target Potential

HLA-J is a protein that is expressed in the human body and is involved in the immune response. As a result, HLA-J has been identified as a potential drug target. One of the main reasons for its potential as a drug target is its involvement in the T-cell response. T-cells are a crucial part of the immune system, as they are responsible for recognizing and responding to foreign substances in the body. HLA-J is the receptor for the T-cell receptor, which is responsible for triggering an immune response.

In addition to its role in the T-cell response, HLA-J has also been shown to play a role in the regulation of inflammation. When the immune system is activated, HLA-J helps to regulate the production of inflammatory cytokines, which can contribute to the development of inflammatory diseases.

Biomarker Potential

HLA-J has also been identified as a potential biomarker for several diseases, including cancer, autoimmune diseases, and inflammatory diseases. One of the main reasons for its potential as a biomarker is its expression in various tissues and cell types in the human body. This makes it a reliable indicator of disease status, as the expression of HLA-J is often reduced in diseases such as cancer and autoimmune diseases.

In addition to its potential as a biomarker, HLA-J has also been shown to be involved in the regulation of immune cell function. For example, studies have shown that HLA-J plays a role in the regulation of T-cell proliferation and differentiation. This suggests that HLA-J may be a useful target for drugs that are designed to enhance or inhibit the immune system.

Conclusion

In conclusion, HLA-J is a human leukocyte antigen (HLA) class I molecule that is expressed in various tissues and cell types in the human body. Its involvement in the immune system and its potential as a drug target and biomarker make it an attractive target for research and development of new therapies. Further studies are needed to fully understand the role of HLA-J in the immune system and its potential as a drug and biomarker.

Protein Name: Major Histocompatibility Complex, Class I, J (pseudogene)

More Common Targets